Does VALSARTAN Cause Cerebral atrophy? 11 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Cerebral atrophy have been filed in association with VALSARTAN (valsartan). This represents 0.1% of all adverse event reports for VALSARTAN.
11
Reports of Cerebral atrophy with VALSARTAN
0.1%
of all VALSARTAN reports
3
Deaths
6
Hospitalizations
How Dangerous Is Cerebral atrophy From VALSARTAN?
Of the 11 reports, 3 (27.3%) resulted in death, 6 (54.5%) required hospitalization, and 2 (18.2%) were considered life-threatening.
Is Cerebral atrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VALSARTAN. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does VALSARTAN Cause?
Drug ineffective (1,845)
Blood pressure increased (1,682)
Dizziness (1,527)
Headache (1,361)
Hypertension (1,341)
Acute kidney injury (1,301)
Dyspnoea (1,239)
Fatigue (1,156)
Malaise (1,139)
Hypotension (1,032)
What Other Drugs Cause Cerebral atrophy?
FINGOLIMOD (87)
VALPROIC ACID (84)
PHENYTOIN (58)
METHOTREXATE (55)
LEVETIRACETAM (54)
CYCLOPHOSPHAMIDE (52)
OLANZAPINE (52)
CARBIDOPA\LEVODOPA (50)
VALPROATE (50)
OCRELIZUMAB (48)
Which VALSARTAN Alternatives Have Lower Cerebral atrophy Risk?
VALSARTAN vs VALTREX
VALSARTAN vs VAMOROLONE
VALSARTAN vs VANCOMYCIN
VALSARTAN vs VANDETANIB
VALSARTAN vs VARDENAFIL